Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,076,614

« Back to Dashboard

Which drugs does patent 10,076,614 protect, and when does it expire?

Patent 10,076,614 protects ONZETRA XSAIL and XHANCE and is included in two NDAs.

This patent has sixteen patent family members in twelve countries.

Summary for Patent: 10,076,614

Title:	Nasal delivery devices
Abstract:	A nasal delivery device for delivering substance to a nasal cavity of a subject comprises: a housing (15); a nosepiece (17) for fitting to a nasal cavity of the subject; a mouthpiece (19) through which the subject in use exhales; and a flexible coupling (20) which couples the mouthpiece to the housing, wherein the flexible coupling provides for asymmetric translation of the mouthpiece relative to the nosepiece.
Inventor(s):	Djupesland; Per Gisle (Oslo, NO), Gordon; Joseph (Mansfield, MA), Leclerc; Michael (Cranston, RI), Mahmoud; Ramy A (Skillman, NJ), Siwinski; Shane (Providence, RI)
Assignee:	OptiNose AS (Oslo, NO)
Application Number:	14/380,801
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 10,076,614
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,076,614

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Avanir Pharms	ONZETRA XSAIL	sumatriptan succinate	POWDER;INHALATION	206099-001	Jan 27, 2016		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Optinose Us Inc	XHANCE	fluticasone propionate	SPRAY, METERED;NASAL	209022-001	Sep 18, 2017		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 10,076,614

PCT Information
PCT Filed	February 25, 2013	PCT Application Number:	PCT/EP2013/053747
PCT Publication Date:	August 29, 2013	PCT Publication Number:	WO2013/124492

International Family Members for US Patent 10,076,614

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013223973	➤ Sign Up
Canada	2865353	➤ Sign Up
China	104428026	➤ Sign Up
European Patent Office	2817054	➤ Sign Up
Hong Kong	1205699	➤ Sign Up
India	7611DEN2014	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.